The results from the three independent glioma cohorts showed that the DNAJC10 expressions were up-regulated in higher WHO grade gliomas (Figure 2B, Wilcoxon rank-sum test), which was consistent with the result of IHC images from HPA dataset. This evidence concerns the gene DNAJC10 and central nervous system cancer.